Navigation Links
STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
Date:1/14/2010

stelarainfo.com/">www.STELARAinfo.com.

Centocor Ortho Biotech Inc. discovered STELARA and has exclusive marketing rights to the product in the United States.  Janssen-Cilag companies have exclusive marketing rights in all countries outside of the United States.  STELARA is approved in 44 countries around the world including Canada, Europe and the United States for the treatment of moderate-to-severe plaque psoriasis.

Important Safety Information

STELARA™ is a prescription medicine that affects your immune system. STELARA™ can increase your chance of having serious side effects including:

Serious Infections

STELARA™ may lower your ability to fight infections and may increase your risk of infections. While taking STELARA™, some people have serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.

  • Your doctor should check you for TB before starting STELARA™ and watch you closely for signs and symptoms of TB during treatment with STELARA™.
  • If your doctor feels that you are at risk for TB, you may be treated for TB before and during treatment with STELARA™.

You should not start taking STELARA™ if you have any kind of infection unless your doctor says it is okay.

Before starting STELARA, tell your doctor if you think you have an infection or have symptoms of an infection such as:

  • fever, sweats, or chills
  • muscle aches
  • cough
  • shortness of breath
  • blood in your phlegm
  • '/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Intec Pharma Ltd. (the "Company") (NASDAQ: NTEC ... drugs based on its proprietary Accordion Pill platform technology, ... in the United States of ... the public of $6.00 per ordinary share, before underwriting ... being offered by the Company.  In addition, the Company ...
(Date:8/4/2015)... , Aug. 4, 2015 Concord Medical Services ... leading specialty hospital management solution provider and operator of the ... China , today announced it will release its ... market closes on August 17, 2015. Management will ... day, at 8:00 a.m. EDT on August 18, 2015 (8:00 ...
(Date:8/4/2015)... 4, 2015 BioElectronics Corporation (OTC Pink: ... Pain Therapy medical devices, announced today that its ... 7-day trial device has been published in the ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic ... an assessment.  Chronic pain is ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2
... International, Inc. (Nasdaq: HTWR ; ASX: HIN), ... technologies that are revolutionizing the treatment of advanced heart ... to make an investor presentation at the UBS 2010 ... 12:30 pm EDT.  The conference will be held September ...
... KING OF PRUSSIA, Pa., Sept. 15 ... into a strategic alliance with Campbell Informatics, an integrated ... alliance of Tunnell, a leading life sciences industry consultancy, ... life sciences manufacturers, suppliers and regulators, is designed to ...
Cached Medicine Technology:HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2Tunnell Consulting Forms Strategic Alliance With Ireland-Based Campbell Informatics 2
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, ... of Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this ... to save and improve lives by promoting the safety, quality and availability of ...
(Date:8/4/2015)... Raton, FL (PRWEB) , ... August 04, 2015 ... ... diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced ... but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a ...
(Date:8/4/2015)... ... 04, 2015 , ... Angelina Jolie is in it at age 39. “It” ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the ... out of menopause. , Myth #1: Menopause only affects old ladies. – Menopause ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... Rise of Local Food,” scheduled for Nov. 3 – 4, 2015, at UC ... food sustainably, create new businesses, improve food access, and manage resources efficiently against ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... 24/7 ... County, Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of ... indicate that 24/7 Care At Home’s agency is well on the path to meeting ...
Breaking Medicine News(10 mins):Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3
... Md., Nov. 6 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... commercializing novel anti-infective products, today,announced that three patents ... the FDA Orange Book on,Oct. 24, 2008, pursuant ... which was,enacted on Oct. 8, 2008., MiddleBrook ...
... Nektar,Therapeutics (Nasdaq: NKTR ) today announced that it ... debt for approximately 48,cents on the dollar, for a ... its financial results for the third quarter and,nine-months ended ... now largely complete," said Nektar,President and CEO Howard W. ...
... Sysmex further expands the value and capabilities ... 6 Sysmex America, Inc. (SAI), a,leading ... today announced the launch of e-Verify(TM), the ... said,John Kershaw, President, Sysmex America, Inc. e-Verify ...
... effects on vitality unclear, scientists say , , THURSDAY, Nov. ... restore the amounts of muscle-linked growth hormone in seniors ... on the therapy also gained muscle mass over the ... that this led to significant improvements in their strength ...
... Ad Campaign Calling for "Health Reform We Can Believe In" ... ... president of Partnership for Prevention said today that President-elect Obama,s call ... health promotion a cornerstone of any health reform effort. Accordingly, the ...
... Third quarter revenues increase 65 percent versus third quarter last ... Conference Call at 4:30 p.m. Eastern Time Today, ... ), the worldwide leader in intravascular temperature,management (IVTM(TM)) therapies for ... progress for the third quarter and,nine months ended September 30, ...
Cached Medicine News:Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Sysmex America to Release e-Verify(TM), Powered By SNCS(TM) 2Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • unit ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: